These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27578283)

  • 21. Vaccines to prevent and treat autoimmune diseases.
    Mor F; Cohen IR
    Int Arch Allergy Immunol; 1995 Dec; 108(4):345-9. PubMed ID: 7580306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective immunosuppression.
    Adorini L; Guéry JC; Rodriguez-Tarduchy G; Trembleau S
    Immunol Today; 1993 Jun; 14(6):285-9. PubMed ID: 8104410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [T cell vaccination--induction of anti-idiotypic immune response against TCR and shift of Th1/Th2 balance].
    Kakimoto K; Hara H
    Nihon Rinsho; 1997 Jun; 55(6):1512-8. PubMed ID: 9200941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmunity, immunologic tolerance, and gene therapy.
    Chen Y
    Immunol Res; 1998; 17(1-2):33-40. PubMed ID: 9479565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases.
    Sauer EL; Cloake NC; Greer JM
    Int Rev Immunol; 2015; 34(6):460-85. PubMed ID: 25970132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell receptor and alloimmune thrombocytopenias: a model for autoimmune diseases?
    Yassai M; McFarland JG; Newton-Nash D; Newman PJ; Eckels DD; Gorski J
    Ann Med Interne (Paris); 1992; 143(6):365-70. PubMed ID: 1295386
    [No Abstract]   [Full Text] [Related]  

  • 27. Gene therapy for tolerance and autoimmunity: soon to be fulfilled promises?
    El-Amine M; Melo ME; Scott DW
    Clin Immunol; 2001 Apr; 99(1):1-6. PubMed ID: 11286536
    [No Abstract]   [Full Text] [Related]  

  • 28. The compleat angler: aggressive mimicry in an antennariid anglerfish.
    Pietsch TW; Grobecker DB
    Science; 1978 Jul; 201(4353):369-70. PubMed ID: 17793734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells.
    de Zoeten EF; Hancock WW
    Gastroenterology; 2008 Jun; 134(7):2171-4. PubMed ID: 18482583
    [No Abstract]   [Full Text] [Related]  

  • 30. Insights into autoimmunity: from classical models to current perspectives.
    Gutierrez-Ramos JC; Andreu JL; Moreno de Alboran I; Rodriguez J; Leonardo E; Kroemer G; Marcos MA; Martinez C
    Immunol Rev; 1990 Dec; 118():73-101. PubMed ID: 2079329
    [No Abstract]   [Full Text] [Related]  

  • 31. Autoimmune diseases and HLA.
    Nelson JL; Hansen JA
    Crit Rev Immunol; 1990; 10(4):307-28. PubMed ID: 2285459
    [No Abstract]   [Full Text] [Related]  

  • 32. [The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease].
    Miller A; Weiner HL; Abramsky O
    Harefuah; 1992 Aug; 123(3-4):110-5. PubMed ID: 1516860
    [No Abstract]   [Full Text] [Related]  

  • 33. [Costimulatory molecules, CD 80 and CD 86].
    Takasaki Y
    Ryumachi; 1998 Aug; 38(4):623-30. PubMed ID: 9785992
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immune intervention by peptides having a MHC class II binding motif--application of MHC blockers to autoimmune disease models].
    Nihira S
    Nihon Rinsho; 1997 Jun; 55(6):1525-30. PubMed ID: 9200943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy.
    Wang ZH; Liao YH; Yuan J; Zhang L; Wang M; Zhang JH; Liu ZP; Dong JH
    Chin Med J (Engl); 2007 Aug; 120(15):1319-25. PubMed ID: 17711737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.
    Pentcheva-Hoang T; Corse E; Allison JP
    Immunol Rev; 2009 May; 229(1):67-87. PubMed ID: 19426215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network.
    Weathington NM; Blalock JE
    Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in the study of molecular mechanisms, applications and screening for altered peptide ligand].
    Wang QQ; Yang HZ; Hu ZW
    Yao Xue Xue Bao; 2008 Feb; 43(2):113-7. PubMed ID: 18507334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen-specific targeting of CD8+ T cells with receptor-modified T lymphocytes.
    Nguyen P; Geiger TL
    Gene Ther; 2003 Apr; 10(7):594-604. PubMed ID: 12646865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The multichain interleukin-2 receptor: from the gene to the bedside.
    Waldmann TA
    Harvey Lect; 1986-1987; 82():1-17. PubMed ID: 3129378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.